Objective: To assess the incidence and determinants of the triple inhaled therapy in chronic obstructive pulmonary disease (COPD) primary care patients. Methods: Data derived from the Health Search Database (HSD) gathering information on 700 Italian general practitioners. A cohort of COPD patients, prescribed for the first time with inhaled treatments, was followed-up between January 2002 and December 2014. The outcome was the first incident prescription of a triple inhaled therapy, namely the combination of inhaled corticosteroids (ICS), long-acting beta agonists (LABA), and long-acting muscarinic antagonists (LAMA). Cox regressions were used to test the association (hazard ratios, HR) between candidate determinants and the outcome. Result...
Background: Real-world prescription pathways leading to triple therapy (TT) (inhaled corticosteroid ...
Abstract Background Guidelines recommend that treatme...
Purpose: Inhaled corticosteroids (ICS) are often more widely prescribed in the treatment of chronic ...
Objective: To assess the incidence and determinants of the triple inhaled therapy in chronic obstruc...
Introduction: The development of new pharmacological treatments for chronic obstructive pulmonary di...
textabstractBackground: Real-world prescription pathways leading to triple therapy (TT) (inhaled cor...
This real-world study compared the effectiveness of triple therapy (TT; long-acting muscarinic antag...
Purpose: Inappropriate use of an inhaled corticosteroid (ICS) for COPD has clinical and economic dis...
COPD is a leading cause of death and disability. COPD therapy goals include reducing exacerbations a...
There is limited information about the initiation of triple therapy (TT) in patients with chronic ob...
Jason C Simeone,1 Rakesh Luthra,2 Shuchita Kaila,2 Xiaoyun Pan,1 Tarun D Bhagnani,1 Jieruo Liu,1 Ter...
Abstract Introduction Maintenance treatment strategies in COPD recommend inhaled corticosteroid (ICS...
Brian Lipworth, Chris RuiWen Kuo, Sunny Jabbal Division of Molecular & Clinical Medicine, Scott...
Triple inhaled corticosteroid (ICS)/long-acting muscarinic antagonist (LAMA)/long-acting β2-agonist ...
Introduction 2021 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Reports recommends t...
Background: Real-world prescription pathways leading to triple therapy (TT) (inhaled corticosteroid ...
Abstract Background Guidelines recommend that treatme...
Purpose: Inhaled corticosteroids (ICS) are often more widely prescribed in the treatment of chronic ...
Objective: To assess the incidence and determinants of the triple inhaled therapy in chronic obstruc...
Introduction: The development of new pharmacological treatments for chronic obstructive pulmonary di...
textabstractBackground: Real-world prescription pathways leading to triple therapy (TT) (inhaled cor...
This real-world study compared the effectiveness of triple therapy (TT; long-acting muscarinic antag...
Purpose: Inappropriate use of an inhaled corticosteroid (ICS) for COPD has clinical and economic dis...
COPD is a leading cause of death and disability. COPD therapy goals include reducing exacerbations a...
There is limited information about the initiation of triple therapy (TT) in patients with chronic ob...
Jason C Simeone,1 Rakesh Luthra,2 Shuchita Kaila,2 Xiaoyun Pan,1 Tarun D Bhagnani,1 Jieruo Liu,1 Ter...
Abstract Introduction Maintenance treatment strategies in COPD recommend inhaled corticosteroid (ICS...
Brian Lipworth, Chris RuiWen Kuo, Sunny Jabbal Division of Molecular & Clinical Medicine, Scott...
Triple inhaled corticosteroid (ICS)/long-acting muscarinic antagonist (LAMA)/long-acting β2-agonist ...
Introduction 2021 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Reports recommends t...
Background: Real-world prescription pathways leading to triple therapy (TT) (inhaled corticosteroid ...
Abstract Background Guidelines recommend that treatme...
Purpose: Inhaled corticosteroids (ICS) are often more widely prescribed in the treatment of chronic ...